A simple way to promote HPV vaccination among Asian American women: Storytelling

The Conversation, March 4, 2020 10.58pm AEDT

Why do so many Asian Americans and Pacific Islander women know so little about HPV? We set out to answer this question by interviewing  ethnic groups and conducting surveys.

Our findings suggest their knowledge and attitudes toward HPV prevention are closely tied to health beliefs and cultural or language barriers. What’s more, we discovered preventive health care is not a top priority for immigrant populations. In general, they seek treatment only when already sick. Our studies also suggest many of them are skeptical about participating in research.

We discovered in our study that narrative storytelling – that is, mothers and their children sharing their experiences and having conversations about HPV vaccination – can increase HPV vaccination rates.

From that, we’ve developed what we call a storytelling intervention for young Korean American women using a “peer-paired” approach. Because the storytellers are about the same age as the participants, a meaningful conversation is more likely to occur. The women are less shy about sharing their personal experiences, feelings and fears.

High-risk behaviors and their association with awareness of HIV status among participants of a prevention intervention

High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece.

Pavlopoulou, I.D., Dikalioti, S.K., Gountas, I. et al.

BMC Public Health 20, 105 (2020). https://doi.org/10.1186/s12889-020-8178-y

Abstract

Background

Aristotle was a seek-test-treat intervention during an outbreak of human immunodeficiency virus (HIV) infection among people who inject drugs (PWID) in Athens, Greece that started in 2011. The aims of this analysis were: (1) to study changes of drug injection-related and sexual behaviors over the course of Aristotle; and (2) to compare the likelihood of risky behaviors among PWID who were aware and unaware of their HIV status.

Methods

Aristotle (2012–2013) involved five successive respondent-driven sampling rounds of approximately 1400 PWID each; eligible PWID could participate in multiple rounds. Participants were interviewed using a questionnaire, were tested for HIV, and were classified as HIV-positive aware of their status (AHS), HIV-positive unaware of their status (UHS), and HIV-negative. Piecewise linear generalized estimating equation models were used to regress repeatedly measured binary outcomes (high-risk behaviors) against covariates.

Results

Aristotle recruited 3320 PWID (84.5% males, median age 34.2 years). Overall, 7110 interviews and blood samples were collected. The proportion of HIV-positive first-time participants who were aware of their HIV infection increased from 21.8% in round A to 36.4% in the last round. The odds of dividing drugs at least half of the time in the past 12 months with a syringe someone else had already used fell from round A to B by 90% [Odds Ratio (OR) (95% Confidence Interval-CI): 0.10 (0.04, 0.23)] among AHS and by 63% among UHS [OR (95% CI): 0.37 (0.19, 0.72)]. This drop was significantly larger (p = 0.02) among AHS. There were also decreases in frequency of injection and in receptive syringe sharing in the past 12 months but they were not significantly different between AHS (66 and 47%, respectively) and UHS (63 and 33%, respectively). Condom use increased only among male AHS from round B to the last round [OR (95% CI): 1.24 (1.01, 1.52)].

Conclusions

The prevalence of risky behaviors related to drug injection decreased in the context of Aristotle. Knowledge of HIV infection was associated with safer drug injection-related behaviors among PWID. This highlights the need for comprehensive interventions that scale-up HIV testing and help PWID become aware of their HIV status.

Post Exposure Prophylaxis (PEP) for HIV: An overview for Health Professionals

SHINE SA, October 2018

Access to PEP after an eligible exposure to HIV is a medical emergency. Your response to patients presenting for PEP can support them in preventing a life-long infection with HIV.

A brief, online training module has been created to support health professionals to:

• Increase your understanding of PEP as an emergency presentation and vital HIV prevention measure
• Assist you in providing patients with optimal care and support when seeking PEP in the emergency setting

This course is designed for Medical Officers and Registered Nurses in hospital emergency departments and targeted primary care clinical and rural sites that hold PEP starter packs in South Australia.

  • To register for the free PEP training module, please email us here with your name, position and workplace.

SA Health has contributed funds towards this program.

Indigenous Risk Impact Screen Training – Upcoming Dates

Drug and Alcohol Services South Australia (DASSA), August 2018

DASSA’s Aboriginal Workforce Development team would like to invite you to attend the 2-day Indigenous Risk Impact Screen training workshop.

The Indigenous Risk Impact Screen is a validated culturally appropriate and widely used tool for screening substance use and mental disorders in Aboriginal clients. It has been developed in partnership with Aboriginal communities and is used throughout Australia. The purpose of the training is to provide participants with the skills to screen, assess and deliver these clients, a brief intervention that is culturally secure. The workshop includes training in the use of the IRIS screening instrument, a two factor screen that assesses alcohol and other drugs and associated mental health issues.

The target audience is people working in the health and community sector who have contact with Aboriginal and Torres Strait Islander clients who may have emotional health and/or alcohol and other drug issues.

The training is free to attend. Sessions will be held in Adelaide (booked out), Ceduna, Coober Pedy & Mount Gambier. Please see attached promotional document for details with date and venue.

Exploring HIV risks, testing and prevention among sub-Saharan African community members in Australia

International Journal for Equity in Health, 2018, 17:62

https://doi.org/10.1186/s12939-018-0772-6

Abstract

Background

Significant health disparities persist regarding new and late HIV diagnoses among sub-Saharan African (SSA) communities in Australia. Personal/cultural beliefs and practices influence HIV (risk, prevention, testing) within Australia and during visits to home countries.

Method

A community forum was conducted involving 23 male and female adult African community workers, members and leaders, and health workers; facilitated by cultural workers and an experienced clinician/researcher. The forum comprised small/large group discussions regarding HIV risk/prevention (responses transcribed verbatim; utilising thematic analysis).

Results

Stigma, denial, social norms, tradition and culture permeated perceptions/beliefs regarding HIV testing, prevention and transmission among African Australians, particularly regarding return travel to home countries.

Conclusions

International travel as a risk factor for HIV acquisition requires further examination, as does the role of the doctor in HIV testing and Pre-exposure Prophylaxis (PrEP). Further assessment of PrEP as an appropriate/feasible intervention is needed, with careful attention regarding negative community perceptions and potential impacts.

Scotland’s reduction in new HCV infections is due to harm reduction, not treatment

infohep, Published:12 June 2018

The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and opioid substitution therapy, rather than a reduction in the number of people with hepatitis C as a result of increased treatment of HCV infection, a modelling study published in the journal Addiction reports.

Researchers from the University of Bristol and three Scottish universities developed a model of the Scottish HCV epidemic to test the impact of varying levels of harm reduction provision.